Gleevec 400 MG tablet 10S
Ended Awarded
- Contract number
- SPE2DB25FX49Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,021
Award facts
- Contract value 100% obligated
- $14,020.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,020.85 to AmerisourceBergen Drug Corp for the supply of Gleevec 400 mg tablets (10-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete transaction under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare systems through its comprehensive portfolio of brand-name and generic medications, vaccines, and medical devices. The SPE2DX prime contract functions as a global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Gleevec, a specialized oncology medication, exemplifies the company's capacity to fulfill federal medical procurement requirements for critical pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DB25FX49Z?
SPE2DB25FX49Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FX49Z worth?
The government has obligated $14,021 on SPE2DB25FX49Z.
Is contract SPE2DB25FX49Z an order under another contract?
Yes. SPE2DB25FX49Z is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX49Z competed?
The extent of competition for SPE2DB25FX49Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award